MedTrace Logo

A Trial of SHR7280 in Healthy Subjects

NCT06969664 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2025-08-19

No results posted yet for this study

Summary

The study is being conducted to evaluate the effect of high-fat meal on pharmacokinetics of SHR7280 after oral administration and the effect of SHR7280 on QT interval at low and high doses in healthy Chinese volunteers.

Conditions

  • Endometriosis
  • Uterine Fibroids
  • Assisted Reproduction

Interventions

DRUG

SHR7280 Tablet

Oral SHR7280 tablet.

DRUG

SHR7280 Placebo Tablet

Oral SHR7280 placebo tablet.

Sponsors & Collaborators

  • Jiangsu HengRui Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-19
Primary Completion
2025-07-05
Completion
2025-07-05

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06969664 on ClinicalTrials.gov